Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop
cancer cells from growing. Drugs used in chemotherapy use different ways to stop cancer cells
from dividing so they stop growing or die. Combining biological therapy with chemotherapy may
kill more cancer cells.
PURPOSE: Phase I trial to study the effectiveness of biological therapy after chemotherapy in
treating patients who have relapsed or refractory non-Hodgkin's lymphoma.